PAVmed Inc. (PAVM) Financial Ratios
11 years of historical data (2014–2024) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
N/A
—
5yr avg: 3.16
30Y Low2.4·High3.9
ROE
↓
N/A
—
5yr avg: -162.3%
30Y Low-249%·High-69%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PAVM Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
PAVmed Inc. trades at 14.4x earnings, 1038% above its 5-year average of 1.3x, sitting at the 100th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.3x, the stock trades at a discount of 36%.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $466M | $41M | $30M | $43M | $191M | $101M | $36M | $21M | $31M | $90M | — |
| Enterprise Value | $497M | $72M | $59M | $40M | $113M | $98M | $38M | $21M | $31M | $89M | — |
| P/E Ratio → | 14.39 | 1.26 | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 155.65 | 13.68 | 12.15 | 113.41 | 381.38 | — | — | — | — | — | — |
| P/B Ratio | — | — | — | 3.91 | 2.40 | — | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
PAVM EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 23.92 | 24.01 | 105.17 | 226.86 | — | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | 2.52 | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
PAVM Profitability
Margins and return-on-capital ratios measuring operating efficiency
PAVmed Inc. earns an operating margin of -1485.4%. Operating margins have expanded from -24161.0% to -1485.4% over the past 3 years, signaling improving operational efficiency.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -101.6% | -101.6% | -161.8% | -858.6% | -17.0% | — | — | — | — | — | — |
| Operating Margin | -1485.4% | -1485.4% | -2805.7% | -24161.0% | -10878.6% | — | — | — | — | — | — |
| Net Profit Margin | 1328.6% | 1328.6% | -2617.3% | -23602.9% | -10069.4% | — | — | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | — | — | -197.0% | -127.5% | — | — | — | — | -3589.5% | -248.7% |
| ROA | 124.8% | 124.8% | -147.4% | -126.3% | -94.3% | -253.7% | -202.5% | -354.5% | -758.5% | -542.2% | -172.8% |
| ROIC | -232.4% | -232.4% | -800.3% | -1368.1% | — | — | — | — | — | — | — |
| ROCE | — | — | — | -197.6% | -137.8% | — | — | — | — | -3589.5% | -248.7% |
PAVM Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $31M ($32M total debt minus $1M cash).
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | 3.35 | — | — | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | — | — | -0.28 | -0.97 | — | — | — | — | — | -1.21 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -988.60 | -988.60 | -116.80 | -71.11 | — | -440.58 | -437.61 | -4.42 | -11.09 | — | — |
PAVM Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.06x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 1.07x to 0.06x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | 0.06 | 0.45 | 1.07 | 10.93 | 0.94 | 0.55 | 0.77 | 0.64 | 0.62 | 1.34 |
| Quick Ratio | 0.05 | 0.05 | 0.44 | 1.06 | 10.86 | 0.89 | 0.55 | 0.77 | 0.64 | 0.62 | 1.34 |
| Cash Ratio | 0.03 | 0.03 | 0.36 | 1.04 | 10.49 | 0.87 | 0.52 | 0.75 | 0.60 | 0.49 | 1.32 |
| Asset Turnover | — | 0.10 | 0.07 | 0.01 | 0.01 | — | — | — | — | — | — |
| Inventory Turnover | 22.70 | 22.70 | 11.91 | 13.85 | 1.11 | — | — | — | — | — | — |
| Days Sales Outstanding | — | 2.19 | 9.08 | 16.46 | 146.00 | — | — | — | — | — | — |
PAVM Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
PAVmed Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business. The earnings yield of 6.9% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | 0.0% | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 6.9% | 79.1% | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Shares Outstanding | — | $65M | $7M | $6M | $5M | $3M | $2M | $1M | $899730 | $864810 | $887333 |
Peer Comparison
Compare PAVM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PAVMYou | $466M | 14.4 | — | — | -101.6% | -1485.4% | — | -232.4% | — |
 NVCR | $2B | -13.8 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 INVA | $2B | 6.9 | 8.1 | 9.9 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 MGRX | $6M | -0.1 | — | — | 61.7% | -1294.4% | -118.3% | -83.8% | — |
 ATEC | $1B | -8.1 | 3752.1 | 422.6 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 GKOS | $8B | -40.9 | — | — | 77.5% | -17.1% | -26.4% | -9.2% | — |
 TMDX | $3B | 15.0 | 18.4 | 18.9 | 59.9% | 17.9% | 54.2% | 18.8% | 3.5 |
 PRCT | $1B | -14.8 | — | — | 63.7% | -33.7% | -24.9% | -55.7% | — |
 MDT | $100B | 21.6 | 14.3 | 19.3 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 BSX | $84B | 29.2 | 25.3 | 23.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 SYK | $113B | 35.0 | 20.3 | 26.3 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
| Healthcare Median | — | 22.3 | 14.5 | 18.5 | 64.0% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 11 years · Updated daily
See PAVM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PAVM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PAVM vs NVCR
Side-by-side business, growth, and profitability comparison vs NovoCure Limited.
Start ComparisonPAVM — Frequently Asked Questions
Quick answers to the most common questions about buying PAVM stock.
What is PAVmed Inc.'s P/E ratio?
PAVmed Inc.'s current P/E ratio is 14.4x. The historical average is 1.3x. This places it at the 100th percentile of its historical range.
Is PAVM stock overvalued?
Based on historical data, PAVmed Inc. is trading at a P/E of 14.4x. This is at the 100th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are PAVmed Inc.'s profit margins?
PAVmed Inc. has -101.6% gross margin and -1485.4% operating margin.